---
schema_version: "secwatch.filing_event.v1"
accession: "0000784199-23-000084"
form_type: "8-K"
ticker: "AORT"
cik: "0000784199"
company_name: "ARTIVION, INC."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T23:40:36.062585+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Artivion Q1 revenue $83.2M (+8% GAAP, +10% constant currency); raises FY guidance

## Summary
- Net loss ($13.5M) or ($0.33)/share; non-GAAP net income $769k ($0.02)/share.
- On-X revenue up 24% constant currency; aortic stent grafts up 8% constant currency.
- FY 2023 revenue guidance raised to $337-348M (prev. $331-343M); constant currency growth now 9-12%.
- Adjusted EBITDA guidance increased to >$52M (prev. >$50M); EBITDA growth >25% YoY expected.
- FDA issued Approvable Letter for PerClot PMA; $14.3M milestone payment expected after final approval.

## SEC filing metadata
- accession: 0000784199-23-000084
- form_type: 8-K
- ticker: AORT
- cik: 0000784199
- company_name: ARTIVION, INC.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/784199/000078419923000084/0000784199-23-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/784199/000078419923000084/aort-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000784199-23-000084
- JSON: https://secwatch.observer/filing/0000784199-23-000084.json
- Plain text: https://secwatch.observer/filing/0000784199-23-000084.txt

## Key facts
- Earnings Releases
  ARTIVION, INC. updated its full year 2023 guidance (raised).
  - Period: full year 2023
  - Guidance: raised
  - Result: guidance update
  source text: Artivion is raising its revenue guidance range and now expects constant currency revenue growth of between 9% and 12%, compared to the previous range of between 8% and 12%, for the full year 2023 compared to 2022. The Company expects revenues to be in a range of between $337.0 million and $348.0 million, compared to the previous range of between $331.0 million and $343.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/784199/000078419923000084/0000784199-23-000084-index.htm
- Earnings Releases
  ARTIVION, INC. reported first quarter ended March 31, 2023 results: revenue $83.2 million, net income ($13.5) million, EPS ($0.33) per fully diluted common share.
  - Period: first quarter ended March 31, 2023
  - Revenue: $83.2 million
  - Net income: ($13.5) million
  - EPS: ($0.33) per fully diluted common share
  - Result: reported results
  source text: Total revenues for the first quarter of 2023 were $83.2 million, an increase of 8% on a GAAP basis and an increase of 10% on a non-GAAP constant currency basis, both compared to the first quarter of 2022. Net loss for the first quarter of 2023 was ($13.5) million, or ($0.33) per fully diluted common share, compared to net loss of ($3.4) million, or ($0.08) per fully diluted common share for the first quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/784199/000078419923000084/0000784199-23-000084-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.